Literature DB >> 8873674

Relative role of alkalosis and sodium ions in reversal of class I antiarrhythmic drug-induced sodium channel blockade by sodium bicarbonate.

E Bou-Abboud1, S Nattel.   

Abstract

BACKGROUND: Hypertonic sodium salts are used to treat sodium channel-blocking drug cardiotoxicity. The relative roles of alkalinization and increased sodium concentration ([Na+]o) for various drugs are incompletely known. METHODS AND
RESULTS: The effects of four class I drugs on action potential characteristics of canine Purkinje fibers at equieffective concentrations (disopyramide 30 mumol/L, mexiletine 80 mumol/L, flecainide 7 mumol/L, imipramine 5 mumol/L) were studied in the presence of normal Tyrode solution and one altered solution (increased [Na+]o, increased bicarbonate concentration, or both) in each experiment. Combined increases in sodium and bicarbonate concentration significantly reduced the depressant effects of flecainide, imipramine, and mexiletine on phase 0 upstroke (Vmax) but did not alter the effects of disopyramide. The effects of sodium bicarbonate were entirely due to alkalinization in the case of imipramine, but both alkalinization and increased [Na+]o contributed to the interaction with flecainide and mexiletine. The reversal of Vmax depression by increased [Na+]o and pH was due in part to hyperpolarization. In addition, alkalosis directly reversed the hyperpolarizing shift in Vmax inactivation caused by flecainide and imipramine without altering the shift caused by disopyramide and mexiletine.
CONCLUSIONS: Increases in sodium bicarbonate concentration reverse the effects of class I antiarrhythmic drugs to a varying extent, with drug-specific contributions of the sodium and bicarbonate moiety. The molecular basis for this drug specificity remains to be elucidated, but it has important potential implications for the use of hypertonic sodium salts to treat cardiotoxicity caused by sodium channel-blocking drugs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8873674     DOI: 10.1161/01.cir.94.8.1954

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Pharmacology and Toxicology of Nav1.5-Class 1 anti-arrhythmic drugs.

Authors:  Dan M Roden
Journal:  Card Electrophysiol Clin       Date:  2014-12-01

2.  Brugada electrocardiographic pattern elicited by cyclic antidepressants overdose.

Authors:  Wilma E Monteban-Kooistra; Maarten P van den Berg; Jaap E Tulleken; Jack J M Ligtenberg; John H J M Meertens; Jan G Zijlstra
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

Review 3.  A Literature Review of the Use of Sodium Bicarbonate for the Treatment of QRS Widening.

Authors:  Rebecca E Bruccoleri; Michele M Burns
Journal:  J Med Toxicol       Date:  2016-03

Review 4.  Safety of flecainide.

Authors:  Juan Tamargo; Alessandro Capucci; Philippe Mabo
Journal:  Drug Saf       Date:  2012-04-01       Impact factor: 5.606

5.  Fatal flecainide intoxication.

Authors:  E Brazil; G G Bodiwala; D C Bouch
Journal:  J Accid Emerg Med       Date:  1998-11

6.  Flecainide toxicity in renal failure.

Authors:  Rogin Subedi; Ryan K Dean; Arbind Chaudhary; Tamas Szombathy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-09

Review 7.  The Role of Sodium Bicarbonate in the Management of Some Toxic Ingestions.

Authors:  Aibek E Mirrakhimov; Taha Ayach; Aram Barbaryan; Goutham Talari; Romil Chadha; Adam Gray
Journal:  Int J Nephrol       Date:  2017-08-08

8.  Broad complex rhythm with a salty taste.

Authors:  M Boulaksil; C L Meuwese; R Evertz; M G M Kolff-Kamphuis
Journal:  Neth Heart J       Date:  2017-05       Impact factor: 2.380

9.  Management of life-threatening flecainide overdose: A case report and review of the literature.

Authors:  Nancy M Vu; Terence E Hill; Matthew R Summers; Michael N Vranian; Michael D Faulx
Journal:  HeartRhythm Case Rep       Date:  2015-12-29

Review 10.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.